MedTrace Logo

ERCP in Super-aged Patients Considering Difficult Cannulation: Challenges and Adverse Events

NCT03771547 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 614

Last updated 2018-12-11

No results posted yet for this study

Summary

Today 11 percent of China's population is over the age of 65, and according to United Nations, it will take China just 20 years for the proportion of the elderly population to double to 25%. As life expectancy has increased, application of Endoscopic Retrograde Cholangiopancreatography (ERCP) in super-aged (≥80 years of age) is no longer limited with increasing prevalence of choledocholithiasis, and malignancy in advancing age. This increasing may come with more difficulty in cannulation or more complications in senior patients. Regarding difficult cannulation, little is known about grading difficulty in the elderly and its relation with adverse events. Therefore, it is time to evaluate the risk factors of adverse events in super-aged patients with difficult bile duct cannulation.

Conditions

  • Post-ERCP Acute Pancreatitis
  • Cholangitis

Interventions

DIAGNOSTIC_TEST

ERCP

Sponsors & Collaborators

  • The Second Hospital of Nanjing Medical University

    lead OTHER

Principal Investigators

  • Lin Miao, PhD · Nanjing Medical University

Eligibility

Min Age
16 Years
Max Age
94 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-01
Primary Completion
2018-01-30
Completion
2018-03-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03771547 on ClinicalTrials.gov